AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Apr 2012 07:00 AM
RNS
1st Quarter Results
25 Apr 2012 09:00 AM
RNS
Notice of Results
25 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
24 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
23 Apr 2012 07:00 AM
RNS
Acquires Ardea Biosciences for $1 billion
23 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
20 Apr 2012 02:17 PM
RNS
FORXIGA gets positive CHMP opinion in the EU
20 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
19 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
18 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
17 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
16 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
13 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
12 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
11 Apr 2012 04:30 PM
RNS
Annual Information Update
11 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
10 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
05 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
04 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
03 Apr 2012 07:00 AM
RNS
Partners Amgen to develop inflammation portfolio
03 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 03:30 PM
RNS
Total Voting Rights
02 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
30 Mar 2012 04:00 PM
RNS
Director/PDMR Shareholding
30 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
30 Mar 2012 07:00 AM
RNS
US Court Finds Seroquel XR Patent Valid
29 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
29 Mar 2012 07:00 AM
RNS
Filing of Annual Report on Form 20-F with SEC
29 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
28 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
28 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
28 Mar 2012 05:00 PM
RNS
Director/PDMR Shareholding
28 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
27 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
26 Mar 2012 11:40 AM
RNS
Annual Financial Report
26 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
26 Mar 2012 07:00 AM
RNS
US Court dismisses lawsuit against the FDA
23 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
22 Mar 2012 10:25 AM
RNS
UK Court finds Seroquel XR patent invalid
22 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
21 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
20 Mar 2012 07:00 AM
RNS
TC-5214 Phase III studies do not meet endpoint
20 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
19 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
16 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
15 Mar 2012 07:00 AM
RNS
Transaction in Own Shares
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100